Arrowhead Pharmaceuticals Aktie
18,85
EUR
-0,03
EUR
-0,16
%
19,76
USD
+0,20
USD
+1,02
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
12.02.18 | Arrowhead Pharmaceuticals Neutral | Cantor Fitzgerald | |
12.02.18 | Arrowhead Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
05.01.18 | Arrowhead Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
30.11.16 | Arrowhead Pharmaceuticals Mkt Perform | William Blair | |
30.11.16 | Arrowhead Pharmaceuticals Hold | Cantor Fitzgerald | |
30.11.16 | Arrowhead Pharmaceuticals Neutral | Chardan Capital Markets | |
09.10.14 | Arrowhead Pharmaceuticals Sector Perform | RBC Capital Markets |
Werbung